Selenium and arsenic concentrations in blood and changes in the HRG gene as risk factors for cancers and all-cause mortality in women with a hereditary predisposition to breast cancer
PL451713A1Pending Publication Date: 2026-10-12READ GENE SPOKA AKCYJNA
0 Cites 0 Cited by
Patent Information
- Application Number
- PL2025451713
- Authority / Receiving Office
- PL · PL
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-04-07
- Publication Date
- 2026-10-12
Abstract
Unexpectedly, a correlation was found between the risk of cancer and all-cause mortality and the concentration of selenium and arsenic in a whole blood sample, along with the assessment of HRG gene variations. Excessively low and high blood selenium and arsenic concentrations indicate an increased risk of all-cause mortality and mortality among women with a hereditary predisposition to breast cancer, depending on HRG gene variations.
Need to check novelty before this filing date? Find Prior Art